scholarly journals Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database

2015 ◽  
Vol 30 (6) ◽  
pp. 988-995 ◽  
Author(s):  
M. Iwagami ◽  
H. Yasunaga ◽  
E. Noiri ◽  
H. Horiguchi ◽  
K. Fushimi ◽  
...  
2021 ◽  
Author(s):  
Jorge not provided not provided Machado Alba

Introduction: Acute kidney injury is characterized by a sudden decrease in renal function. The objective was to determine the variables that are associated with the need for continuous renal replacement therapy and its outcome in critically ill patients treated in two intensive care units. Methods. A cohort follow-up study with reviewed clinical histories of 140 patients admitted between January-2012 and July-2015, who were receiving continuous therapy, and the main outcome was survival after discharge. Clinical variables, severity scores, disease prognosis, continuous renal replacement techniques and outcomes were collected. Results. Mean age was 61.9±17.6 years, and 60.7% were men. Septic shock was the main cause of acute kidney injury. In total, 79.4% of cases died in the intensive care units. The median dose of continuous renal replacement therapy was 28 ml/kg/hour (interquartile range: 35-37). The late initiation of the therapy between 25-72 hours after the diagnosis increased the probability that the patient would experience a fatal outcome (OR:6.9, 95%CI:1.5-33.0). Conclusions: Acute kidney injury secondary to sepsis is a frequent condition in critically ill patients and is associated with high mortality rates. In these cases, continuous renal replacement therapy was the main recourse for its treatment.


2021 ◽  
Author(s):  
Luming Zhang ◽  
Zichen Wang ◽  
Fengshuo Xu ◽  
Yinlong Ren ◽  
Didi Han ◽  
...  

Abstract Background: Sepsis has high incidence and fatality rates in intensive care units, often leading to renal failure. The effectiveness of continuous renal replacement therapy (CRRT) in sepsis-associated acute kidney injury (S-AKI) patients is currently uncertain.Aim: Joint mode was used to determine the effect of CRRT on the lactate levels and survival of S-AKI patients.Methods: A retrospective study was applied to patients with sepsis and AKI, which were extracted from the MIMIC-III public database, with the endpoint being 28-day mortality. Every lactate level measurement within 28 days was observed and calculated using logarithms. Joint model combined the longitudinal analysis of the natural logarithm of the lactate level [log(lactate)] in longitudinal submodel and Cox regression by trajectory function, demonstrating the effects of CRRT on 28-day survival and log(lactate) changes, and its final relationship with the event status.Results: Among the 717 S-AKI patients, 157 received CRRT. CRRT was not associated with 28-day mortality. After adjustments, the relationship between CRRT use and log(lactate) elevation was statistically significant. The parameter estimation of CRRT and log(lactate) indicated that using CRRT will increase log(lactate) by 0.041 in S-AKI patients. The joint model also instigated a fixed association between changes in the lactate level and the event result, revealing an exp value of (1.755) =5.78, indicating that an increase of one unit in log(lactate) will increase the risk of 28-day mortality 5.78-fold. Conclusion: CRRT does not improve the prognosis of patients with sepsis and acute kidney injury in critical-care units and has a tendency of increasing lactate levels, which is a significant risk factor for the prognosis.


Sign in / Sign up

Export Citation Format

Share Document